Perry Elliott

University College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (29)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (16)

Luis Lopes

Associate Professor

University College London

UNITED KINGDOM

View details

Gabriella Captur

UNITED KINGDOM

View details

james moon

University College London

UNITED KINGDOM

View details

Matthew Wheeler

Associate Professor

Stanford University

UNITED STATES

View details

Mathias Gautel

Head

King’s College London

UNITED KINGDOM

View details

Monika Gladka

Assistant Professor

Amsterdam UMC

NETHERLANDS

View details

Gemma Chiva-Blanch

Professora Agregada

Universitat de Girona

SPAIN

View details

Cynthia James

Assistant Professor

Johns Hopkins University

UNITED STATES

View details

Kevin Mills

University College London

UNITED KINGDOM

View details

Cecilia LInde

Karolinska University Hospital

SWEDEN

View details

Michal Tendera

Professor

Medical University of Silesia

POLAND

View details

Juan Gimeno Blanes

Associate Professor

Universidad de Murcia

SPAIN

View details

Jens Mogensen

Aalborg University

DENMARK

View details

Cornelia Van Duijn

Professor

University of Oxford

UNITED KINGDOM

View details

julien barc

INSERM

FRANCE

View details

Caroline Coats

University of Glasgow

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Perry Elliott

Research Interests

Explore related searches

Contact this professor

Articles (29)

Importance of basic science and research training for the future generation of cardiologists

Integration of genetic testing into diagnostic pathways for cardiomyopathies: a clinical consensus statement by the ESC Council on Cardiovascular Genomics

Tailored therapeutics for cardiomyopathies

Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

Cardiomyopathy caused by mitochondrial DNA 4300A &gt; G variant

Education in cardiovascular genomics and genetics: time for action

Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiomyopathies in low-resource settings

European Heart Journal: a call to action

Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry

A Proof of Principle 2D Spatial Proteome Mapping Analysis Reveals Distinct Regional Differences in the Cardiac Proteome

REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA -Related Dilated Cardiomyopathy

Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease

Novel Multiplexed Plasma Biomarker Panel Has Diagnostic and Prognostic Potential in Children With Hypertrophic Cardiomyopathy

Transatlantic differences in the use of implantable cardioverter defibrillators in arrhythmogenic right ventricular cardiomyopathy

Genetic basis of right and left ventricular heart shape

The International Cardiomyopathy Network: a manifesto for change

Association of Echocardiographic Parameters and Health Status in Patients With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCM

Personalized medicine in sports cardiology: managing the known unknowns

Management of arrhythmogenic right ventricular cardiomyopathy

Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion

Do apical aneurysms predict sudden cardiac death in hypertrophic cardiomyopathy?

Towards a New Classification of Cardiomyopathies

Effect of beta‐blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy

Polygenic risk scores for the prediction of cardiometabolic disease

Long-term survival in people with transthyretin amyloid cardiomyopathy who took tafamidis: A Plain Language Summary

Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy

Performance of the PRIMaCY sudden death risk prediction model for childhood hypertrophic cardiomyopathy: implications for implantable cardioverter-defibrillator decision-making

Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study

Response by Elliott et al to Letter Regarding Article, “Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy”

Collaborators (16)

Luis Lopes

Gabriella Captur

james moon

Matthew Wheeler

Mathias Gautel

Monika Gladka

Gemma Chiva-Blanch

Cynthia James

Kevin Mills

Cecilia LInde

Michal Tendera

Juan Gimeno Blanes

Jens Mogensen

Cornelia Van Duijn

julien barc

Caroline Coats

Make your next move.

Cardiomyopathy caused by mitochondrial DNA 4300A > G variant